JOURNAL OF PEDIATRIC ORTHOPAEDICS, vol.35, no.6, 2015 (SCI-Expanded)
Background Context: The incidence of glucocorticoid-induced osteoporosis is approximately 50% in patients treated for > 6 months, and in the long-term usage fracture risk is approximately 34%. The awareness of pediatric vertebral fractures due to glucocorticoid-induced osteoporosis is increasing. Although most of these fractures are asymptomatic, a small number of children may have severe pain.